MRNA Dividend: Moderna Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

MRNA Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,232	3,236	6,848	19,263	18,471	803
Revenue Growth (YoY)	-56%	-53%	-64%	4%	2,200%	1,238%
Cost of Revenue	815	969	2,493	5,416	2,617	8
Gross Profit	1,417	2,267	4,355	13,847	15,854	795
Selling, General & Admin	1,061	1,174	1,549	1,132	567	188
Research & Development	3,479	4,543	4,845	3,295	1,991	1,370
Operating Expenses	4,540	5,717	6,394	4,427	2,558	1,559
Other Non Operating Income (Expenses)	-5	-7	-14	4	-12	3
Pretax Income	-3,153	-3,607	-3,942	9,575	13,285	-745
Income Tax Expense	-37	-46	772	1,213	1,083	3
Net Income	-3,116	-3,561	-4,714	8,362	12,202	-747
Net Income Growth	40%	-24%	-156%	-31%	-1,732.99%	45%
Shares Outstanding (Diluted)	390	384	382	416	431	381
Shares Change (YoY)	-2%	1%	-8%	-3%	13%	15%
EPS (Diluted)	-7.98	-9.27	-12.34	20.1	28.31	-1.96
EPS Growth	43%	-25%	-161%	-28.99%	-1,544%	26%
Free Cash Flow	-2,663	-4,055	-3,825	4,581	13,336	1,960
Free Cash Flow Per Share	-6.82	-10.55	-10.01	11.01	30.94	5.14
Gross Margin	63.48%	70.05%	63.59%	71.88%	85.83%	99%
Operating Margin	-139.91%	-106.61%	-29.77%	48.9%	71.98%	-95.01%
Profit Margin	-139.6%	-110.04%	-68.83%	43.4%	66.06%	-93.02%
Free Cash Flow Margin	-119.31%	-125.3%	-55.85%	23.78%	72.19%	244.08%
EBITDA	-2,915	-3,261	-1,418	9,768	13,528	-732
EBITDA Margin	-130.6%	-100.77%	-20.7%	50.7%	73.23%	-91.15%
D&A For EBITDA	208	189	621	348	232	31
EBIT	-3,123	-3,450	-2,039	9,420	13,296	-763
EBIT Margin	-139.91%	-106.61%	-29.77%	48.9%	71.98%	-95.01%
Effective Tax Rate	1.17%	1.27%	-19.58%	12.66%	8.15%	-0.4%